Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Axalta Coating Systems Ltd (AXTA): Are Hedge Funds Right About This Stock?

Is Axalta Coating Systems Ltd (NYSE:AXTA) a good bet right now? We like to analyze hedge fund sentiment before doing days of in-depth research. We do so because hedge funds and other elite investors have numerous Ivy league graduates, expert network advisers, and supply chain tipsters working or consulting for them. There is not a shortage of news stories covering failed hedge fund investments (for some reason media paid a ton of attention to Ackman’s gigantic JC Penney and Valeant failures) and it is a fact that hedge funds’ picks don’t beat the market 100% of the time, but their consensus picks have historically done very well and have outperformed the market after adjusting for risk.

When it comes to Axalta Coating Systems Ltd (NYSE:AXTA), investors should be aware of an increase in hedge fund sentiment in recent months. To get a better sense of the stock’s popularity, at the end of this article we will also compare AXTA to other stocks including Westinghouse Air Brake Technologies Corp (NYSE:WAB), Aqua America Inc (NYSE:WTR), and Packaging Corp Of America (NYSE:PKG) to get a better sense of its popularity.

Follow Axalta Coating Systems Ltd. (NYSE:AXTA)
Trade (NYSE:AXTA) Now!

We follow over 700 hedge funds and other institutional investors and by analyzing their quarterly 13F filings, we identify stocks that they are collectively bullish on and develop investment strategies based on this data. One strategy that outperformed the market over the last year, involves selecting the 100 best-performing funds and identifying the 30 mid-cap stocks that they are collectively most bullish on. Over the past year, this strategy generated returns of 18%, topping the 8% gain registered by S&P 500 ETFs.

Now, let’s analyze the key action surrounding Axalta Coating Systems Ltd (NYSE:AXTA).

What does the smart money think about Axalta Coating Systems Ltd (NYSE:AXTA)?

At the end of the third quarter, a total of 49 of the hedge funds tracked by Insider Monkey were long this stock, a change of 14% from one quarter earlier. With hedge funds’ positions undergoing their usual ebb and flow, there exists an “upper tier” of notable hedge fund managers who were upping their holdings meaningfully (or already accumulated large positions).


According to publicly available hedge fund and institutional investor holdings data compiled by Insider Monkey, Warren Buffett’s Berkshire Hathaway has the most valuable position in Axalta Coating Systems Ltd (NYSE:AXTA), worth close to $659.4 million, accounting for 0.5% of its total 13F portfolio. On Berkshire Hathaway’s heels is Iridian Asset Management, led by David Cohen and Harold Levy, holding a $416 million position; 3.6% of its 13F portfolio is allocated to the company. Remaining members of the smart money with similar optimism contain Ric Dillon’s Diamond Hill Capital, Vinit Bodas’s Deccan Value Advisors and Lou Simpson’s SQ Advisors.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.